Research Topics
| Amy DavidoffSummaryAffiliation: University of Maryland Country: USA Publications
| Collaborators
|
Detail Information
Publications
Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluationAmy J Davidoff
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Med Care 47:1229-36. 2009..Recent healthcare system and environmental changes may have reduced treatment gaps...- Use and spending on antineoplastic therapy for Medicare beneficiaries with cancerAmy J Davidoff
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Med Care 51:351-60. 2013..Oral antineoplastic drugs, not generally covered by Medicare Part B, have assumed an increasingly important role in cancer treatment... - Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancerAmy J Davidoff
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
Cancer 119:1257-65. 2013..In the current study, the authors examined out-of-pocket (OOP) spending and burden relative to income for Medicare beneficiaries with cancer... 
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
Haematologica 97:128-32. 2012..Specialist access, financial resources and mobility are key determinants of receipt of erythropoiesis-stimulating agents among myelodysplastic syndrome patients...- Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?Amy J Davidoff
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, USA
Health Aff (Millwood) 29:1255-63. 2010..Our findings emphasize the need to expand eligibility and improve policies to foster enrollment... - Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerAmy J Davidoff
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch St, 12th Floor, Room 214, Baltimore, MD 21201, USA
J Clin Oncol 28:2191-7. 2010..This study extends recent population-based analyses focusing on treatment and survival benefit from use of platinum-doublet therapy, and addressing the role of performance status (PS)... 
Effects of managed care on service use and access for publicly insured children with chronic health conditionsAmy Davidoff
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
Pediatrics 119:956-64. 2007..Our goal was to estimate the effects of managed care program type on service use and access for publicly insured children with chronic health conditions...- Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff
University of Maryland Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
J Thorac Oncol 6:934-41. 2011..Combined modality therapy (CMT; radiation and chemotherapy) is indicated for fit, elderly patients with inoperable, locally advanced non-small cell lung cancer. We used population level data to examine effects of CMT on survival... - Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancerIlene H Zuckerman
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
J Am Geriatr Soc 57:1403-10. 2009..To estimate the modifying effect of age on the survival benefit associated with adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer... - Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetesBruce Stuart
Pharmaceutical Health Services Research Department, The Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
Med Care 50:913-9. 2012..It is not known whether low-income subsidies (LIS) under Medicare Part D help beneficiaries overcome impediments to medication use associated with poor socioeconomic status and high disease burden... - Does medication adherence lower Medicare spending among beneficiaries with diabetes?Bruce Stuart
Epidemiology and Public Health, School of Medicine, University of Maryland Baltimore and Baltimore County, 660 W Redwood St, Baltimore, MD 21201, USA
Health Serv Res 46:1180-99. 2011.... - Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary diseaseBruce C Stuart
Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
Am J Geriatr Pharmacother 8:441-53. 2010..However, little research has been conducted to compare use versus nonuse of these medications in terms of health-related outcomes in routine practice... - Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetesAmy Davidoff
Pharmaceutical Health Services Research, Department School of Pharmacy, University of Maryland Baltimore, Baltimore, MD 21201, USA
Value Health 15:404-11. 2012..To examine cost responsiveness and total costs associated with a simulated "value-based" insurance design for statin therapy in a Medicare population with diabetes... - Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromesSheila Weiss Smith
Center for Drug Safety, University of Maryland School of Pharmacy, Baltimore, Maryland, 220 Arch Street 12 Floor, Baltimore, Maryland, USA 21201
Haematologica 97:15-20. 2012..It is not clear whether erythropoiesis stimulating agents are associated with an increased risk of thrombosis in myelodysplastic syndromes, as they are among patients with solid tumors... - Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?Bruce Stuart
Pharmaceutical Health Services Research Department, The Peter Lamy Center for Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
Am J Geriatr Pharmacother 8:201-14. 2010..Influenza vaccinations are effective in reducing respiratory infections in younger populations, but it is less certain whether they reduce costs associated with respiratory infections among older adults... - Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plansBruce Stuart
Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, 220 Arch St Baltimore, MD 21230, USA
Med Care 49:511-5. 2011..The question for policy makers is whether beneficiaries enrolled in Part D plans exhibit drug utilization patterns comparable with those seen in retiree plans... - Are there differential effects of managed care on publicly insured children with chronic health conditions?Amy Davidoff
University of Maryland Baltimore
Med Care Res Rev 65:356-72. 2008.... - Effects of the State Children's Health Insurance Program Expansions on children with chronic health conditionsAmy Davidoff
Department of Public Policy, University of Maryland Baltimore County, 21250, USA
Pediatrics 116:e34-42. 2005..To estimate the effects of the State Children's Health Insurance Program (SCHIP) expansions on insurance coverage, use of health care services, and access to care for children with chronic health conditions... - The effect of parents' insurance coverage on access to care for low-income childrenAmy Davidoff
Urban Institute, Washington DC 20037, USA
Inquiry 40:254-68. 2003..Although the magnitude of these effects is small relative to the direct effect of providing insurance to either the child or parent, they should be considered in analyses of costs and benefits of proposed policies...